Literature DB >> 14689089

[Hypoglycemia, classification, therapy and preventable errors].

R Lobmann1, H Lehnert.   

Abstract

Hypoglycemia is a multifactorial problem that is caused by the interaction of numerous variables such as a individual pathophysiological response, treatment aspects and self control. In particular, the increasing use of intensified insulin therapy and thus the goal of normoglycemia has made hypoglycaemia to become a major hazard among the acute complications of diabetes mellitus. Early diagnosis and treatment is thus mandatory to reduce the increased morbidity and mortality of hypoglycaemia. Among the acute therapy of hypoglycaemia treatment includes a modification of diabetes therapy, patient education and a special training of hypoglycaemia awareness.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14689089     DOI: 10.1007/s00108-003-1052-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  32 in total

Review 1.  Diabetic hypoglycaemia.

Authors:  S R Heller
Journal:  Baillieres Best Pract Res Clin Endocrinol Metab       Date:  1999-07

2.  Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

Authors:  H Yki-Järvinen; A Dressler; M Ziemen
Journal:  Diabetes Care       Date:  2000-08       Impact factor: 19.112

3.  Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia.

Authors:  A Holstein; A Plaschke; C Hammer; E-H Egberts
Journal:  Eur J Clin Pharmacol       Date:  2003-04-16       Impact factor: 2.953

4.  Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide.

Authors:  A Holstein; A Plaschke; E H Egberts
Journal:  Diabetes Metab Res Rev       Date:  2001 Nov-Dec       Impact factor: 4.876

5.  The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus.

Authors:  S P Laing; A J Swerdlow; S D Slater; J L Botha; A C Burden; N R Waugh; A W Smith; R D Hill; P J Bingley; C C Patterson; Z Qiao; H Keen
Journal:  Diabet Med       Date:  1999-06       Impact factor: 4.359

6.  Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control.

Authors:  W L Clarke; L A Gonder-Frederick; F E Richards; P E Cryer
Journal:  Diabetes       Date:  1991-06       Impact factor: 9.461

7.  Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.

Authors:  K Hermansen; S Madsbad; H Perrild; A Kristensen; M Axelsen
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

8.  Risk factors of severe hypoglycaemia in adult patients with Type I diabetes--a prospective population based study.

Authors:  I Mühlhauser; H Overmann; R Bender; U Bott; M Berger
Journal:  Diabetologia       Date:  1998-11       Impact factor: 10.122

9.  U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.

Authors: 
Journal:  Diabetes       Date:  1995-11       Impact factor: 9.461

10.  Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans.

Authors:  S R Heller; P E Cryer
Journal:  Diabetes       Date:  1991-02       Impact factor: 9.461

View more
  1 in total

1.  [Hypoglycemia despite hyperglycemia. Is a cerebral glucose deficiency possible even with raised blood sugar levels?].

Authors:  G Erdös; R Lobmann; B Wolcke; C Werner
Journal:  Anaesthesist       Date:  2005-07       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.